Reshaping the Immunosuppressive Tumor Microenvironment: The Fusion Protein Strategy
Journal: Cell & Cellular Life Sciences Journal (Vol.1, No. 1)Publication Date: 2016-05-12
Authors : Yanzhang Wei;
Page : 1-6
Keywords : Cancer; Immunotherapy; Fusion protein; Tumor microenvironment;
Abstract
Advanced tumor cells often create immunosuppressive tumor microenvironment to block immune system's attack in defense. The conversion of the environment from immunosuppressive to immune active holds hopes for effective cancer immunotherapies. Fusion proteins coupled with appropriate delivery approaches represent a promising strategy for this conversion. In the last decade, a variety of fusion cytokine proteins (GPI-anchored IL-2/IL-12, RGD/Fc, MULT1E/FasTI, MULT1E/IL-12, and IL-12/FasTI) have been created and tested for their anti-cancer activities in a series of in vitro and in vivo studies. The efforts are going on to develop effective method to deliver the fusion proteins specifically into tumors.
Other Latest Articles
- Prediction Analysis Techniques of Data Mining: A Review
- Analysis of Various Credit Card Fraud Detection Techniques
- Mast Cells, T regulatory Cells, Myeloid-derived Suppresor Cells and their Role in Prognosis of Different Tumors
- INVESTIGATION STUDENTS’ INTENSIVE LISTENING THROUGH CALL (COMPUTER ASSISTED LANGUAGE LEARNING) IN EFL CLASSROOM
- RESEARCH ON THE EVALUATION OF INNOVATION CAPABILITY OF INDUSTRIAL ENTERPRISES IN CHINA'S PROVINCES BASED ON FACTOR ANALYSIS AND CLUSTER ANALYSIS
Last modified: 2019-05-10 20:35:30